PURPOSE: To develop a standardized method for tibial tunnel volumetric bone mineral density (BMD) analysis with quantitative computed tomography (qCT) using cadaveric specimens to provide validation of this technique on a healthy control population and to determine whether osteopenia occurs following an anterior cruciate ligament (ACL) injury. Methods: qCT was used to develop a volumetric BMD (mg/cm3) measurement technique throughout the region of a standard tibial tunnel. This method was applied to 90 lower extremities, including 10 matched cadaveric knees, 10 matched healthy knees, 25 ACL-injured knees, and 25 contralateral ACL-uninjured knees. The mean total and segmental (proximal, middle, and distal) tibial tunnel BMD were analyzed. RESULTS: The mean entire tibial tunnel BMD measured 165.8 ± 30.5 mg/cm3 (cadaver), 255.9 ± 28.2 mg/cm3 (healthy control), 290.3 ± 36.4 mg/cm3 (ACL-injured), and 300.1 ± 35.1 (ACL-uninjured). Segmental tibial tunnel BMD demonstrated distal one-third segments as the greatest areas of BMD, followed by proximal one-third, and middle one-third for all cohorts with all pairwise comparisons (P < .001). The mean BMD was significantly greater in the uninjured extremity compared with the injured extremity in the entire tunnel (290.3 vs 300.1; P < .001), proximal (271.2 vs 279.1; P = .002), middle (167.6 vs 179.6; P < .001), and distal segments (432.7 vs 441.7; P = .004) at an average of 8 weeks following ACL injury. CONCLUSIONS: A standardized method to quantitatively measure the volumetric BMD within the region of a standard tibial tunnel for ACL reconstruction was successfully developed and validated. Significant osteopenia of the injured knee occurs following ACL injury when compared with the contralateral uninjured knee. This observation has potential clinical implications for ACL graft tibial fixation and healing. LEVEL OF EVIDENCE: Descriptive diagnostic study, Level III.
PURPOSE: To develop a standardized method for tibial tunnel volumetric bone mineral density (BMD) analysis with quantitative computed tomography (qCT) using cadaveric specimens to provide validation of this technique on a healthy control population and to determine whether osteopenia occurs following an anterior cruciate ligament (ACL) injury. Methods: qCT was used to develop a volumetric BMD (mg/cm3) measurement technique throughout the region of a standard tibial tunnel. This method was applied to 90 lower extremities, including 10 matched cadaveric knees, 10 matched healthy knees, 25 ACL-injured knees, and 25 contralateral ACL-uninjured knees. The mean total and segmental (proximal, middle, and distal) tibial tunnel BMD were analyzed. RESULTS: The mean entire tibial tunnel BMD measured 165.8 ± 30.5 mg/cm3 (cadaver), 255.9 ± 28.2 mg/cm3 (healthy control), 290.3 ± 36.4 mg/cm3 (ACL-injured), and 300.1 ± 35.1 (ACL-uninjured). Segmental tibial tunnel BMD demonstrated distal one-third segments as the greatest areas of BMD, followed by proximal one-third, and middle one-third for all cohorts with all pairwise comparisons (P < .001). The mean BMD was significantly greater in the uninjured extremity compared with the injured extremity in the entire tunnel (290.3 vs 300.1; P < .001), proximal (271.2 vs 279.1; P = .002), middle (167.6 vs 179.6; P < .001), and distal segments (432.7 vs 441.7; P = .004) at an average of 8 weeks following ACL injury. CONCLUSIONS: A standardized method to quantitatively measure the volumetric BMD within the region of a standard tibial tunnel for ACL reconstruction was successfully developed and validated. Significant osteopenia of the injured knee occurs following ACL injury when compared with the contralateral uninjured knee. This observation has potential clinical implications for ACL graft tibial fixation and healing. LEVEL OF EVIDENCE: Descriptive diagnostic study, Level III.
Anterior cruciate ligament (ACL) disruption is a devastating injury that results in substantial bone mineral density (BMD) loss about the knee that can persist after ACL reconstruction.1, 2, 3, 4 The etiology has been attributed to catabolic stress hormones from the inciting injury, subsequent surgery, immobilization, and altered injured extremity weight-bearing.4, 5, 6, 7 Multiple studies have evaluated BMD changes around the knee after an ACL injury and/or reconstruction and have observed the greatest bone loss in the proximal tibia.2, 3, 4, Likewise, biomechanical studies have also confirmed that the proximal tibia is the weak link for graft fixation in ACL reconstruction.9, 10, 11 Clinically, decreases in BMD may also play a role in the propensity for postoperative tibial fractures and decreased strength of interference screw fixation., As a result, certain institutions have begun to use BMD measurements as a decision-making guide for graft fixation.Biomechanical investigations of tibial fixation constructs for ACL reconstruction have been performed demonstrating a lower mean load to failure in cadaveric tibias with a BMD less than 600 mg/cm2 (201 N) and in older cadaveric specimens after ACL reconstruction using a bone–patellar tendon–bone graft.,, Despite this, biomechanical analysis of tibial fixation constructs warrants an accurate assessment of BMD within the region of graft fixation. Dual energy x-ray absorptiometry (DEXA) has been widely employed to evaluate the proximal tibial BMD of test specimens before biomechanical testing of ACL reconstruction fixation constructs, but this method is highly inaccurate. The planar nature of BMD assessment limits the ability of DEXA to differentiate cortical from cancellous bone, which is of critical importance as interference screw fixation strength improves with purchase into dense cortical or subchondral bone., In addition, BMD reports with DEXA are based upon algorithms intended for analysis of the lumbar spine or distal radius, not the proximal tibia. As such, most biomechanical and clinical studies involving ACL injury and reconstruction have depended upon this imprecise modality for BMD assessment within the proximal tibia.1, 2, 3, 4,,8, 9, 10,,Quantitative computed tomography (qCT) has emerged as a precise and valid method to measure BMD within the peripheral long bones, with the ability to distinguish cortical from cancellous bone, and has been used in many biomechanical and clinical ACL-reconstruction studies to overcome the limitations of DEXA.21, 22, 23, 24, 25, 26, 27, 28, 29 However, no standardized method of in vitro or in vivo volumetric BMD assessment have been described that accurately measures the region within the entire tibial tunnel. Furthermore, baseline values for cadaveric specimens, a healthy uninjured patient population, or an ACL-injured patient population have yet to be defined. The purposes of this study were to develop a standardized method for tibial tunnel volumetric BMD analysis with qCT using cadaveric specimens, to provide validation of this technique on a healthy control population, and to determine whether osteopenia occurs following an ACL injury. We hypothesized that qCT would be used to assess volumetric BMD within the region of a standard tibial tunnel for ACL reconstruction and detect osteopenia following an ACL injury.
Methods
Study Population
Cadaveric Specimens
Twenty fresh-frozen cadaveric lower extremities (10 matched pairs, 5 male, 5 female) with a mean age of 76 ± 8.4 years (range: 60-85 years), were obtained from our institutional cadaver bank. The specimens were grossly inspected by an orthopaedic surgeon (P.C.R) and selected only if there was no physical evidence or medical documentation of a previous knee surgery. The soft tissues (skin, subcutaneous fat, muscle, menisci, collateral and cruciate ligaments) adjacent to the proximal tibia were left intact to simulate an environment similar to in vivo qCT scanning.
Validation in a Healthy Control Subject Group
After approval by the institutional and radiation safety review board (Mayo #08-008067), 10 healthy adult volunteers (7 male, 3 female) with a mean age of 35.1 ± 10.2 years (range: 24-55 years) were recruited and underwent qCT scanning of the bilateral knees (n = 20 knees). Volunteers were excluded if there was a positive history of previous knee surgery or significant injury requiring immobilization in either lower extremities, use of any medication known to affect BMD, symptomatic or known lumbar or hip pathology, history of rheumatologic or inflammatory disease, or if the patient was pregnant. Each patient completed a questionnaire evaluating their knee function (Lysholm knee score and the International Knee Documentation Committee [IKDC] subjective knee evaluation score), and activity level (Tegner and University of California – Los Angeles activity level scores [UCLA]). Epidemiologic data (body mass index [BMI]) and age) was obtained to serve as normative data for a healthy (uninjured) population.
ACL Study Group
Concurrently, 25 patients (20 male and 5 female) with a mean age of 25.9 ± 7.7 years (range: 18-48 years) who sustained a complete tear of the ACL were enrolled into the ACL-injured patient study group by one of the 3 senior authors (D.L.D., B.A.L., or M.J.S.) at the time of initial orthopaedic sports medicine consultation over a 3-year period. qCT scans were obtained of the uninjured (n = 25) and injured extremity (n = 25) before ACL reconstructive surgery. Inclusion criteria consisted of patient age ≥18 years old, unilateral knee injury, and magnetic resonance imaging (MRI) confirmation of a complete (grade III) ACL rupture. Patients were excluded if there was MRI evidence of a concomitant rupture (grade III) of the remaining cruciate or collateral ligaments, history of previous knee surgery or significant injury requiring immobilization in either lower extremities, use of any medication known to affect BMD, symptomatic or known lumbar or hip pathology, history of rheumatologic or inflammatory disease, or if the patient was pregnant. All patients completed postinjury knee function scores (Lysholm and IKDC) as well as pre- and postinjury activity level (Tegner and UCLA) scores. Other epidemiologic factors (age and BMI) were obtained to serve as normative data for an ACL disrupted patient population.
Cadaveric Tibial Tunnel BMD Assessment Technique
A single surgeon performed all the procedures. The tibial tunnel was identified and marked with a 2.4-mm guide pin drilled into the proximal tibia using a tibial tunnel guide (Arthrex, Naples, FL) set at 55°. The pin was inserted at 65° from the medial tibial plateau in the coronal plane (Fig 1A). The pin was directed toward the remnant of the ACL insertion on the tibial footprint. The pin was removed and radio-opaque markers were placed at the proximal and distal ends of the guide pin tract (Fig 1B).,
Fig 1
Demonstration of cadaveric tibial tunnel identification. (A) A 2.4-mm guide pin is directed towards the ACL footprint at 55° from the articular surface in the sagittal plane and 65° (white line) from the medial tibial plateau in the coronal plane. Soft tissues have been removed for illustrative purposes. (B) Radio-opaque markers are placed at the proximal and distal ends of the guide pin tract (red line) after pin removal. (ACL, anterior cruciate ligament.)
Demonstration of cadaveric tibial tunnel identification. (A) A 2.4-mm guide pin is directed towards the ACL footprint at 55° from the articular surface in the sagittal plane and 65° (white line) from the medial tibial plateau in the coronal plane. Soft tissues have been removed for illustrative purposes. (B) Radio-opaque markers are placed at the proximal and distal ends of the guide pin tract (red line) after pin removal. (ACL, anterior cruciate ligament.)A single postimaging analysis technician performed the image processing and Hounsfield unit calculation with repeat processing and analysis at a minimum of 1 week from the initial tests. Intraclass correlation coefficients were then calculated based on sampling of baseline and repeat measurements with calculated intraobserved intraclass correlation coefficients demonstrating strong correlations, with values greater than 0.8. qCT was used to assess BMD within the region of the previously identified tibial tunnel. The qCT scans were acquired with a CT scanner protocol (Somatom Definition SD; Seimens Healthcare, Forcheim, Germany) set at collimation of 64 × 0.6, pitch of 1 mm, kernel of B70s, and reconstruction increment of 0.5 mm. The cadaveric tibias were placed on top of a 6-level hydroxyapatite phantom (Model 3 CT Phantom; Mindways Software, Inc., San Francisco, CA) and were visualized within the same field of view.The region of interest (RoI) was a 3-mm thick ring between a 9 mm and 15 mm circle per axial slice centered over the guide pin tract (Fig 2A). Custom software was used to stack the ring RoIs in series along the trajectory of the guide pin tract to provide a cylindrical RoI within the peripheral bone of a potential 9-mm tibial tunnel, at the site of graft–bone or screw–bone interface. The cylindrical RoI was divided into 3 equal regions (proximal one-third, middle one-third, and distal one-third) for segmental BMD analysis (Fig 2B).
Fig 2
Cylindrical, volumetric BMD of the peripheral tibial tunnel (in vitro). (A) A 3-mm ring RoI (green shade), between a 9 mm (yellow shade) and 15 mm (green, yellow, and maroon shade) circular RoI, centered over the guide pin tract (maroon shade). (B) Segmental BMD within the proximal, middle, and distal one thirds of the tibial tunnel (black dotted lines separating segments). (BMD, bone mineral density; RoI, region of interest.)
Cylindrical, volumetric BMD of the peripheral tibial tunnel (in vitro). (A) A 3-mm ring RoI (green shade), between a 9 mm (yellow shade) and 15 mm (green, yellow, and maroon shade) circular RoI, centered over the guide pin tract (maroon shade). (B) Segmental BMD within the proximal, middle, and distal one thirds of the tibial tunnel (black dotted lines separating segments). (BMD, bone mineral density; RoI, region of interest.)BMD assessment was initiated (proximally at the subchondral bone) and terminated (distally at the anterior tibial cortex) where at least 50% of the ring RoI was within bone per axial slice. All non-bone objects (radio-opaque markers and regions outside of the bone) were masked off. The average Hounsfield unit value within the RoI per axial slice was measured, and the volumetric BMD (mg/cm3) was calculated using a calibration curve derived from the phantom per manufacturer protocol.
Control and ACL Injured Patient Tibial Tunnel BMD Assessment Technique
Quantitative CT scans were acquired with the identical protocol used for the cadaveric specimens. The calibration phantom of the healthy controls and the injured knee (ACL injury cohort) were scanned within the same field of view, starting at 6 cm proximal to the femoral notch and ending at 10 cm distal to the tibial articular surface. The location of the tibial tunnel was identified and marked with custom software that allowed for manipulation of a 3-D reconstruction of the proximal tibia. The long axis of the tibial tunnel was established at approximately 55° in the sagittal plane and at 65° to the medial tibial plateau subchondral bone (Fig 3).
Fig 3
In vivo tibial tunnel trajectory identification. The trajectory of the tibial tunnel, 55° from the articular surface in the sagittal plane and 65° from the medial tibial plateau in the coronal plane is selected with the use of custom software that allows for manipulation of a 3-dimensional reconstruction of the proximal tibia.
In vivo tibial tunnel trajectory identification. The trajectory of the tibial tunnel, 55° from the articular surface in the sagittal plane and 65° from the medial tibial plateau in the coronal plane is selected with the use of custom software that allows for manipulation of a 3-dimensional reconstruction of the proximal tibia.The trajectory of the tibial tunnel was directed toward the ACL footprint. The intra-articular starting point (ACL footprint) for the tibial tunnel was identified both in the sagittal and coronal plane. In the sagittal plane, the anterior to posterior distance (millimeter) of the subchondral bone at the medial tibial plateau was noted on the axial images. This value was multiplied by 0.43 (43% of the anterior to posterior distance) to result in the distance from the anterior subchondral bone to the center of the tibial tunnel at the articular surface, through which a horizontal line was marked., In the coronal plane, the midpoint between the medial and lateral tibial spines marked the center of the tibial tunnel at the articular surface, through which a vertical line was marked. The central axis of the tibial tunnel was positioned at the intersection of these lines (Fig 4).
Fig 4
Identification of the ACL footprint for in vivo application. The ACL footprint is identified at the intersection (white circle) of a line draw horizontally at a distance (43% of the anterior to posterior distance of the medial tibial plateau subchondral bone) posterior to the anterior tibial cortex and vertically at the midpoint between the medial and lateral tibial spine. (ACL, anterior cruciate ligament.)
Identification of the ACL footprint for in vivo application. The ACL footprint is identified at the intersection (white circle) of a line draw horizontally at a distance (43% of the anterior to posterior distance of the medial tibial plateau subchondral bone) posterior to the anterior tibial cortex and vertically at the midpoint between the medial and lateral tibial spine. (ACL, anterior cruciate ligament.)Similar to the cadaveric technique, 3-mm thick ring RoIs were generated. The rings were stacked in line with the trajectory of the previously identified trajectory of a standard tibial tunnel to create a cylindrical RoI at the periphery of a potential 9-mm diameter tibial tunnel. Likewise, the cylindrical RoI was divided into 3 equal regions (proximal one-third, middle one-third, and distal one-third) for segmental BMD analysis. BMD assessment was initiated (proximally at the subchondral bone) and terminated (distally at the anterior tibial cortex) where at least 50% of the ring RoI was within bone per axial slice. All non-bone objects (region outside of the bone) were masked off. The mean Hounsfield unit per axial slice within the ring RoI was converted to volumetric BMD (mg/cm3) based upon the calibration phantom.
Statistical Analysis
All analyses were performed with Excel (version 14.0, Microsoft, Redmond, WA) and JMP Pro (version 14.1.0; SAS Institute Inc., Cary, NC), with sample size considered for all calculations. General statistics (mean, standard deviation, median, range, and frequencies) were performed on the subject’s demographic, radiographic, and clinical information when applicable. The Wilcoxon rank-sum test was used to compare means of continuous variables, and the Fisher exact and χ2 tests were used to compare nominal variables, when appropriate. Spearman’s rank correlation coefficient was used to test for significant correlation between demographic and radiologic information and outcome scores. P values < .05 were considered statistically significant.
Results
A total of 90 lower extremities were analyzed, including 10 cadaveric specimens, 10 healthy controls, and 25 ACL-injured patients. Demographic and functional variables are shown in Table 1. The healthy cohort was significantly older than their ACL injured counterparts (35.1 ± 10.2 vs 25.9 ± 7.7; P = .006) with a lower body mass index (24.3 ± 3.1 kg/m2 vs 27.3 ± 1.1 kg/m2; P = .045). Similarly, both Lysholm (83.3 ± 3.9 vs 46.8 ± 23.4; P < .001) and IKDC (96.0 ± 7.1 vs 50.3 ± 17.0; P < .001) knee function scores were significantly greater in the healthy cohort compared to the ACL injured cohort.
Table 1
Baseline Demographic and Descriptive Data of Healthy and ACL-Injured Cohorts
Healthy Control (n = 10)
ACL-Injured (n = 25)
P Value
Age, y ± SD
35.1 ± 10.2
25.9 ± 7.7
.006
Sex
.723
Male
7 (70%)
20 (80%)
Female
3 (30%)
5 (20%)
Height, cm
176.3 ± 6.5
175.1 ± 9.5
.722
Weight, kg
75.7 ± 12.3
83.3 ± 11.9
.143
BMI, mean ± SD
24.3 ± 3.1
27.3 ± 1.1
.045
NOTE. Data are n (%) or mean ± SD, unless stated otherwise.
ACL, anterior cruciate ligament; BMI, body mass index; SD, standard deviation.
Baseline Demographic and Descriptive Data of Healthy and ACL-Injured CohortsNOTE. Data are n (%) or mean ± SD, unless stated otherwise.ACL, anterior cruciate ligament; BMI, body mass index; SD, standard deviation.
Cadaveric Specimens
The mean BMD throughout the entire length of the tibial tunnel and mean segmental BMD for cadaveric knees are listed in Table 2 and Figure 5. The mean segmental BMD was significantly different in pair-wise comparison of proximal to middle (180.2 ± 41.0 mg/cm3 vs 99.3 ± 21.2 mg/cm3; P < .001), proximal to distal segments (180.2 ± 41.0 mg/cm3 vs 217.4 ± 53.1 mg/cm3; P < .001), and distal to middle segments (217.4 ± 53.1 mg/cm3 vs 99.3 ± 21.2 mg/cm3; P < .001). The comparisons between the right and left sides were not statistically significant for the total (P =.501), proximal (P =.342), middle (P =.174), or distal segments (P =.936).
Table 2
Comparison of Entire Tibial Tunnel and Segmental Tibial Tunnel BMD for All Cohorts
Cadavers (n = 20)
Healthy (n = 20)
ACL-Ruptured Extremity (n = 25)
ACL-Uninjured Extremity (n = 25)
Entire tunnel
165.8 ± 30.5
255.9 ± 28.2
290.3 ± 36.4
300.1 ± 35.1
Proximal one-third
180.2 ± 41.0
252.2 ± 35.0
271.2 ± 32.2
279.1 ± 31.3
Middle one-third
99.3 ± 21.2
132.6 ± 22.4
167.6 ± 31.0
179.6 ± 33.1
Distal one-third
217.4 ± 53.1
382.2 ± 53.9
432.7 ± 75.1
441.7 ± 74.6
Segmental differences
Proximal–middle
81.0 ± (63.7-98.3)
119.6 ± (104.0- 135.2)
103.6 ± (88.5- 118.6)
100.7 ± (84.1- 117.1)
Distal–proximal
37.1 ± (10.1- 64.2)
130.0 ± (102.0- 158.0)
161.5 ± (128.8- 194.3)
162.6 ± (128.3- 196.9)
Distal–middle
118.1 ± (98.1- 138.1)
249.6 ± (227.4- 271.8)
265.1 ± (239.5- 290.6)
263 ± (239.8- 286.7)
NOTE. Values represented as mean and standard deviation reported in mg/cm3, except for differences presented as the mean and the 2-tailed 95% confidence interval.
ACL, anterior cruciate ligament; BMD, bone mineral density.
Fig 5
Mean total and segmental BMD within the region of the tibial tunnel in a cadaveric specimen, a healthy uninjured patient, and an ACL ruptured patient. Mean BMD per axial slice is much higher in the proximal (subchondral bone) and distal (anterior tibial cortex) portion of the tibial tunnel compared to the middle (cancellous bone). ∗Represents statistical significance of pairwise comp. (ACL, anterior cruciate ligament BMD, bone mineral density.)
Comparison of Entire Tibial Tunnel and Segmental Tibial Tunnel BMD for All CohortsNOTE. Values represented as mean and standard deviation reported in mg/cm3, except for differences presented as the mean and the 2-tailed 95% confidence interval.ACL, anterior cruciate ligament; BMD, bone mineral density.Mean total and segmental BMD within the region of the tibial tunnel in a cadaveric specimen, a healthy uninjured patient, and an ACL ruptured patient. Mean BMD per axial slice is much higher in the proximal (subchondral bone) and distal (anterior tibial cortex) portion of the tibial tunnel compared to the middle (cancellous bone). ∗Represents statistical significance of pairwise comp. (ACL, anterior cruciate ligament BMD, bone mineral density.)
Healthy Subjects Study Group
The mean BMD throughout the entire tibial tunnel and mean segmental BMD for healthy controls are shown in Table 2 and Figure 5. The mean segmental BMD was significantly different in pair-wise comparison of proximal-to-middle (252.2 ± 35.0 vs 132.6 ± 22.4; P < .001), proximal-to-distal (252.2 ± 35.0 vs 382.2 ± 53.9; P < .001), and distal-to-middle segments (382.2 ± 53.9 vs 132.6 ± 22.4; P < .001). Mean segmental BMD was not statistically different when we compared right and left sides for total (P = .556), proximal (P = .223), middle (P = .348), or distal segments (P = .297).
ACL-Injured Patients Study Group
Of the 25 ACL-injured patients, 60% (n = 15) occurred in their dominant extremity, 88% (n = 22) during a sporting event, and 56% (n =15) due to a contact mechanism of injury. Weight-bearing was restricted for a mean of 13.2 days (range 0-42) after the injury, crutches were used for a mean of 14.8 days (range 0-42), and a knee immobilizer was used for a mean of 10.8 days (range 0-70). These patients underwent qCT scanning at a mean of 8 weeks from injury (range 1-36 weeks). The mean BMD throughout the entire length of the tibial tunnel and mean segmental BMD for the injured knee and contralateral uninjured knee in the ACL group are listed in Table 2 and Figure 5. Comparisons of mean total segment BMD revealed no differences across age, gender, and BMI for the injured (P = .271, P = .266, P = .326) and uninjured extremity (P = .209, P = .309, P = .299).The mean segmental BMD in the ACL ruptured extremity was significantly different in pair-wise comparison of proximal-to-middle (271.2 ± 32.2 vs 167.6 ± 31.0; P < .001), proximal-to-distal (271.2 ± 32.2 vs 432.7 ± 75.1; P < .001), and distal-to-middle segments (432.7 ± 75.1 vs 167.6 ± 31.0; P < .001). The mean segmental BMD in the contralateral ACL-uninjured extremity was also significantly different in pairwise comparison of proximal-to-middle (279.1 ± 31.3 vs 179.6 ± 33.1; P < .001), proximal-to-distal (279.1 ± 31.3 vs 441.7 ± 74.6; P < .001), and distal-to-middle segments (441.7 ± 74.6 vs 179.6 ± 33.1; P < .001). Comparisons between the mean BMD of the ACL injured and uninjured extremity demonstrated higher values in the entire tunnel (290.3 vs 300.1; P < .001), proximal (271.2 vs 279.1; P = .002), middle (167.6 vs 179.6; P < .001), and distal segments (432.7 vs 441.7; P = .004).
Intergroup Analysis
Segmental differences between the healthy, ACL-injured, and ACL-uninjured cohorts demonstrated similar changes in comparison of proximal–middle (P = .201), distal–proximal (P = .285), and distal–middle (P = .619) (Table 2). Further comparison of the healthy control and ACL injured cohorts revealed that the mean BMD was significantly greater in the ACL injured patients in both the injured and uninjured extremities with a difference of 34.4 mg/cm3 (P = .001) and 44.6 mg/cm3 (P < .001) in the entire tunnel, 35.0 mg/cm3 (P < .001) and 46.8 mg/cm3 (P < .001) in the middle segment, and 50.4 mg/cm3 (P = .012) and 59.4 mg/cm3 (P = .005) in the distal segment, respectively (Table 3). BMD was not significantly different in comparison of the healthy control and ACL injured extremity (P = .069); however, the ACL-uninjured extremity had higher BMD values than the healthy cohort with a mean difference of 26.8 (P = .012) mg/cm3.
Table 3
Comparison of Entire Tibial Tunnel and Segmental Tibial Tunnel BMD Between ACL Extremities and Between ACL and Healthy Controls
Entire Tunnel
Proximal One-Third
Middle One-Third
Distal One-Third
ACL cohort comparison
ACL-ruptured extremity
290.3 ± 36.4
271.2 ± 32.2
167.6 ± 31.0
432.7 ± 75.1
ACL-uninjured extremity
300.1 ± 35.1
279.1 ± 31.3
179.6 ± 33.1
441.7 ± 74.6
Difference
9.8 ± (7.0-12.6)
7.9 ± (3.2-12.5)
12.0 ± (7.1-16.9)
9.0 ± (3.3-14.8)
P value
<.001
.002
<.001
.004
Healthy and ACL Cohort comparison
Healthy cohort
255.9 ± 28.2
252.2 ± 35.0
132.6 ± 22.4
382.2 ± 53.9
ACL-injured extremity
290.3 ± 36.4
271.2 ± 32.2
167.6 ± 31.0
432.7 ± 75.1
Difference∗
34.4 ± (14.4-54.4)
18.9 ± (–1.6 to 39.4)
35.0 ± (18.9-51.1)
50.4 ± (11.6-89.3)
P value∗
.001
.069
<.001
.012
ACL-uninjured extremity
300.1 ± 35.1
279.1 ± 31.3
179.6 ± 33.1
441.7 ± 74.6
Difference†
44.6 ± (24.9-61.9)
26.8 ± (6.6- 47.1)
46.8 ± (30.2- 62.3)
59.4 ± (20.7- 98.1)
P value†
<.001
.012
<.001
.005
The values are presented as the mean and the standard deviation reported in mg/cm3, except for differences presented as the mean and the 2-tailed 95% confidence interval.
ACL, anterior cruciate ligament; BMD, bone mineral density.
Differences and P values for the ACL-injured extremity—the healthy cohort.
The ACL-uninjured extremity—the healthy cohort.
Comparison of Entire Tibial Tunnel and Segmental Tibial Tunnel BMD Between ACL Extremities and Between ACL and Healthy ControlsThe values are presented as the mean and the standard deviation reported in mg/cm3, except for differences presented as the mean and the 2-tailed 95% confidence interval.ACL, anterior cruciate ligament; BMD, bone mineral density.Differences and P values for the ACL-injured extremity—the healthy cohort.The ACL-uninjured extremity—the healthy cohort.
Discussion
The main finding of this study is the development of a standardized in vitro and in vivo method to measure the volumetric BMD within the region of a standard tibial tunnel for ACL reconstruction. This technique can assess the clinical region of interest at the periphery of the tibial tunnel at the graft–bone or screw–bone interface. This method of tibial tunnel BMD assessment provided normative BMD for cadaveric specimens and was also validated in a healthy uninjured population. Most importantly, analysis between the ACL-injured and contralateral -uninjured extremity demonstrated that osteopenia can be detected within 8 weeks of injury.Accurate assessment of the entire tibial tunnel BMD with qCT after ACL reconstruction remains an ongoing area of research. Previous investigations on qCT BMD analysis mainly focused on predicting tibial interference screw fixation strength or evaluating effects of graft preconditioning on graft tension.24, 25, 26, 27 Weiler et al. did use qCT to identify a location with adequate BMD (800 mg/cm3) within the bovine tibia to conduct fixation strength testing. Unfortunately, there were no further descriptions of the technique used for BMD assessment in that study, nor in a variety of subsequent biomechanical investigations of ACL graft fixation strength from the same authors, limiting the reproducibility of this method by others.,Similarly, limited standardized methods currently exists for tibial tunnel BMD assessment with qCT in vivo for clinical investigations of ACL reconstructions. Muren et al. performed one of the first in vivo studies with qCT demonstrating no sign of increased BMD in the tibial tunnel 1 year after a bone–patellar tendon–bone graft. As a result, subsequent investigations utilized qCT to evaluate various regions in the proximal tibia to find the optimal location for fixation into the proximal tibia based on BMD. Mariani et al. used qCT to evaluate the difference in trabecular bone structure between the anterior and posterior aspect of the tibia. Subsequently, Lee et al. determined that the anteromedial area of the proximal tibia had the highest density and was likely the most likely to accept an interference screw.However, complete tunnel evaluation is lacking due to the imprecision of these contemporary methods and the wide variability of BMD within the proximal tibia in the axial, coronal, and sagittal planes. Khodadadyan-Klostermann et al. noted that BMD in 40 cadaveric proximal tibias decreased significantly when traveling from proximal to metaphyseal bone and was consistently lowest in the central and anteromedial regions of the proximal tibia compared to other regions in the same axial slice. Similarly, Klein et al. observed significantly greater BMD, with a technique involving immersion of harvested cancellous bone cores, proximally when compared with distally within the proximal tibia of cadaveric specimens. Mariani et al. then reported one of the early clinical studies, demonstrating a significantly greater BMD in the anterior half of the proximal tibia as compared with the posterior half in a group of healthy young patients.A valid assessment of BMD within the region of clinical interest for ACL reconstruction necessitates the measurement of BMD throughout the entire path of the tibial tunnel. Dunkin et al. used a high-resolution qCT to evaluate the bone volume fraction (bone volume/total volume) of a 2-mm thick cylinder around the periphery of the entire tibial tunnel by stacking 2 mm thick ring RoIs (per reconstruction slice) centered over the central axis of a previously extraction drilled tibial tunnel in 20 porcine tibias. Although this technique provides a valid and accurate assessment of bone quality about the tibial tunnel, BMD was not measured. The current study used qCT and a modification of the stacked ring RoI technique to provide an accurate assessment of bone quality throughout the entire path of the tibial tunnel.The tibial tunnel BMD observed in the present study for cadaveric specimens and healthy volunteers is comparable to that reported in the literature for the proximal tibia. In 3 cohorts of cadaveric proximal tibias, with a combined mean age of 40 years (range 17-54), Nurmi et al. noted a mean trabecular BMD of 180 ± 30 mg/cm3, 182 ± 43 mg/cm3, and 176 ± 27 mg/cm3. The region evaluated by Nurmi et al. (2 cm below the articular surface) corresponds to the proximal segment analyzed in the current study with a similar mean segmental BMD of 180 ± 41 mg/cm3 in cadaveric specimens (mean age of 76 years). In healthy volunteers, with a mean age of 39 years (range: 24 to 6 years), Sievanen et al. reported a mean BMD of 167 ± 33 mg/cm3 (range 104-235) and 349 ± 56 mg/cm3 (range 263-500) in the proximal tibial for trabecular and cortical bone, respectively. The region evaluated by Sievanen et al. (at a distal distance of 5% of the total length of the tibia from the lateral tibial plateau subchondral bone) corresponds to the middle (trabecular) and distal (corticocancellous) segments analyzed in the current study, with similar mean middle and distal segmental BMD of 132.6 ± 22.4 mg/cm3 and 382.2 ± 53.9 mg/cm3 in healthy volunteers (mean age of 35 years), respectively.As previously mentioned, literature defining the BMD within the region of the entire tibial tunnel in an ACL injured population remains limited. Bayar et al. noted significant BMD loss (with DEXA) about the injured knee (greatest loss at the medial proximal tibia) in 32 patients at a mean time of 24 months after an ACL disruption. Leppala et al. detected significant BMD loss (with DEXA) within the injured extremity (greatest loss at the proximal tibia and the patella) in 12 patients at a mean time of 12 months after sustaining a complete ACL rupture. Despite innumerable tibial fixation strength biomechanical ACL reconstruction studies, which evaluate the proximal tibia (cadaveric, porcine, or bovine) for adequate and clinically relevant bone quality, the actual BMD within the region of the tibial tunnel for an ACL-ruptured population is unknown. The current study provides normative data for BMD throughout the entire tibial tunnel in an ACL injured population.Most importantly, a greater tibial tunnel BMD was observed in all segments of the contralateral uninjured extremity of the ACL group when compared to the ACL-ruptured extremity. This is in accordance with the results of previous literature which has demonstrated that ACL ruptures can result in substantial BMD loss about the knee despite ACL reconstruction.1, 2, 3, 4 In addition, the proximal tibia is often the area of greatest bone loss.2, 3, 4, While the exact pathophysiology remains unknown, attributable factors include catabolic hormones from the inciting injury, subsequent surgery, immobilization, and altered weight-bearing through the injured extremity.4, 5, 6, 7, By design, the current investigation analyzed BMD before surgical intervention and was still able to detect BMD changes between injured and uninjured extremities at a mean time of 8 weeks from the initial injury to qCT scan. Although this duration may appear relatively short, Nardo et al. demonstrated similar timelines with bone marrow changes being evident on MRI as soon as 10 weeks following brief immobilization. In addition, van Meer et al. observed a difference in DEXA measured BMD between injured and contralateral knees as soon as 10.4 weeks after an ACL injury. As such it is noteworthy the current qCT method can detect early BMD changes after an ACL injury, which may be due to trauma-related factors and/or reduced weight bearing and immobilization.
Limitations
There are several limitations to this study. First, there is potential for variability despite an attempt to standardize the technique with a single surgeon performing all the procedures and a single postimaging analysis technician performing all the processing. The authors aimed to reduce this with a test–retest demonstrating acceptable intraobserver reliability. Second, the authors used a commercially available qCT software with a stacked “ring” technique centered along a guide pin tract on axial images to create a reproducible method of tibial tunnel BMD assessment on any in-vitro specimen. However, the in vivo BMD analysis required custom software development to allow the user to define the trajectory of a standard ACL reconstruction tibial tunnel upon which the stacked “ring” technique could be aligned. Third, this investigation used a total of 90 specimens for analysis based on resource availability. This may represent a small sample size, but the current cohort represents comparable numbers to published cohorts and is unique in the use of qCT. In addition, the investigators attempted to use the combination of cadaveric, healthy host, and ACL ruptured patients to provide an appropriate range of BMD types.
Conclusions
A standardized method to quantitatively measure the volumetric BMD within the region of a standard tibial tunnel for ACL reconstruction was successfully developed and validated. Significant osteopenia of the injured knee occurs following ACL injury when compared to the contralateral uninjured knee. This observation has potential clinical implications for ACL graft tibial fixation and healing.
Authors: Brad S Dunkin; John Nyland; Andrew R Duffee; Jeffrey A Brunelli; Robert Burden; David Caborn Journal: Am J Sports Med Date: 2007-01-11 Impact factor: 6.202
Authors: Jae Chul Yoo; Jin Hwan Ahn; Jae Hoon Kim; Byung Kwan Kim; Kui Won Choi; Tae Soo Bae; Chang Yang Lee Journal: Knee Date: 2006-12 Impact factor: 2.199
Authors: Lorenzo Nardo; David N Sandman; Warapat Virayavanich; Linlin Zhang; Richard B Souza; Lynne Steinbach; Michele Guindani; Thomas M Link Journal: Eur Radiol Date: 2013-07-07 Impact factor: 5.315